Lab
Trincare INC
Trincare INC was paid $1.47M by Medicaid between Jan 2018 and Dec 2024, across 110 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 14% of everything it billed.
33Billing provider infoTRINCARE INC
TYLER, TX 75701
TYLER, TX 75701
33aNPI1033351226assigned 04/02/2009
33bProvider typeClinical Medical Laboratory
28Total paid$1.47M
24GClaims166,332
24DCodes billed110
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#55 of 436
Median peer was paid$17K
This provider vs. median85×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,218 | $30K | |
| 2019 | 4,848 | $28K | |
| 2020 | 11,057 | $144K | |
| 2021 | 18,462 | $163K | |
| 2022 | 20,909 | $149K | |
| 2023 | 50,640 | $460K | |
| 2024incomplete | 55,198 | $497K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 14% | 8,149 | 7,881 | $204K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 14% | 8,115 | 7,850 | $203K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7.5% | 1,424 | 1,401 | $110K |
| 80061 | Lipid panel | 5.2% | 10,963 | 10,517 | $77K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.0% | 19,716 | 18,483 | $73K |
| 86703 | 4.3% | 6,546 | 6,349 | $63K | |
| 84443 | Thyroid stimulating hormone (TSH) | 4.3% | 8,172 | 7,797 | $63K |
| 80050 | General health panel | 4.2% | 2,089 | 2,012 | $62K |
| 80053 | Comprehensive metabolic panel | 3.9% | 13,841 | 13,058 | $58K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.5% | 10,109 | 9,705 | $52K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.3% | 1,345 | 1,306 | $49K |
| 80055 | 3.2% | 1,629 | 1,562 | $47K |
98 more codes
| 88142 | 2.2% | 2,348 | $33K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.1% | 1,281 | $30K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.0% | 6,135 | $29K |
| 86803 | 2.0% | 3,704 | $29K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.6% | 2,303 | $24K |
| 84439 | 1.3% | 3,649 | $19K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 845 | $18K |
| 83655 | 1.1% | 1,838 | $17K | |
| 87070 | 1.1% | 2,769 | $17K | |
| 82105 | 1.1% | 1,428 | $16K | |
| 86592 | 1.1% | 5,269 | $16K | |
| 82728 | <1% | 1,573 | $11K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 613 | $10K |
| 87808 | <1% | 1,645 | $10K | |
| 87340 | <1% | 1,730 | $8K | |
| 82950 | <1% | 2,286 | $7K | |
| 87081 | <1% | 1,621 | $7K | |
| 83970 | <1% | 755 | $6K | |
| 80305 | <1% | 801 | $6K | |
| 86738 | <1% | 542 | $6K | |
| 87186 | <1% | 1,363 | $6K | |
| 80076 | <1% | 1,111 | $5K | |
| 83540 | <1% | 1,546 | $5K | |
| 82570 | <1% | 2,806 | $4K | |
| 86762 | <1% | 531 | $4K | |
| 83550 | <1% | 976 | $4K | |
| 82951 | <1% | 460 | $4K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 87 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,596 | $3K |
| 82607 | <1% | 527 | $3K | |
| 86140 | <1% | 1,366 | $3K | |
| 82247 | <1% | 916 | $3K | |
| 80069 | <1% | 1,319 | $2K | |
| 84702 | <1% | 227 | $2K | |
| 81001 | <1% | 2,872 | $2K | |
| 88141 | <1% | 177 | $2K | |
| 86850 | <1% | 570 | $2K | |
| 86780 | <1% | 287 | $2K | |
| 84156 | <1% | 2,030 | $2K | |
| 82043 | <1% | 1,342 | $2K | |
| 80074 | <1% | 134 | $2K | |
| 82248 | <1% | 654 | $2K | |
| 83021 | <1% | 161 | $2K | |
| 85652 | <1% | 1,231 | $1K | |
| 83013 | <1% | 29 | $1K | |
| 85018 | <1% | 623 | $1K | |
| 87205 | <1% | 383 | $1K | |
| 87210 | <1% | 266 | $1K | |
| 87077 | <1% | 253 | $995.68 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 59 | $950.70 |
| 83735 | <1% | 411 | $882.67 | |
| 84450 | <1% | 261 | $867.80 | |
| 80081 | <1% | 14 | $817.44 | |
| 84460 | <1% | 235 | $763.87 | |
| 86901 | <1% | 501 | $684.63 | |
| 83880 | <1% | 122 | $606.26 | |
| 86900 | <1% | 456 | $550.54 | |
| 86885 | <1% | 84 | $497.77 | |
| 84403 | <1% | 31 | $427.86 | |
| 84481 | <1% | 38 | $404.70 | |
| 83525 | <1% | 55 | $391.42 | |
| 86038 | <1% | 63 | $382.85 | |
| 87088 | <1% | 68 | $341.03 | |
| 87209 | <1% | 27 | $317.10 | |
| 82952 | <1% | 122 | $313.94 | |
| 83001 | <1% | 28 | $267.18 | |
| 87045 | <1% | 40 | $248.19 | |
| 84466 | <1% | 30 | $230.22 | |
| 84146 | <1% | 30 | $226.19 | |
| 82310 | <1% | 478 | $211.36 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 20 | $206.36 |
| 85014 | <1% | 103 | $190.08 | |
| 82565 | <1% | 61 | $189.49 | |
| 84075 | <1% | 58 | $187.01 | |
| 82040 | <1% | 64 | $180.99 | |
| 82746 | <1% | 25 | $172.47 | |
| 83721 | <1% | 58 | $171.70 | |
| 84100 | <1% | 86 | $163.89 | |
| 80051 | <1% | 28 | $148.59 | |
| 84155 | <1% | 64 | $133.51 | |
| 80349 | <1% | 46 | $124.58 | |
| 84520 | <1% | 43 | $117.67 | |
| 82947 | <1% | 45 | $102.70 | |
| 81050 | <1% | 45 | $99.51 | |
| 81025 | <1% | 16 | $93.99 | |
| 83690 | <1% | 13 | $65.41 | |
| 83615 | <1% | 28 | $58.62 | |
| 85610 | <1% | 35 | $48.16 | |
| 86431 | <1% | 13 | $47.60 | |
| 85045 | <1% | 13 | $40.20 | |
| 82465 | <1% | 16 | $24.33 | |
| 81003 | <1% | 16 | $18.72 | |
| 84478 | <1% | 14 | $14.48 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 775 | $10.31 |
| 83718 | <1% | 14 | $2.52 | |
| 80197 | 0% | 315 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 73 | $0.00 |
| 84165 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARRISON, MARY (PROVIDER ENROLLMENT COORDINATOR)
| Provider | Location | Paid |
|---|---|---|
| Lincoln-Way High School District 210 | New Lenox, IL | $124K |
| Trinity Clinic | Henderson, TX | $437.22 |
| Trinity Clinic | Tyler, TX | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.